Compare COHN & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COHN | VVOS |
|---|---|---|
| Founded | 1999 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.6M | 19.4M |
| IPO Year | N/A | 2020 |
| Metric | COHN | VVOS |
|---|---|---|
| Price | $16.61 | $2.11 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | 30.8K | ★ 114.8K |
| Earning Date | 11-04-2025 | 11-19-2025 |
| Dividend Yield | ★ 5.87% | N/A |
| EPS Growth | ★ 6.29 | N/A |
| EPS | ★ 2.50 | N/A |
| Revenue | ★ $185,475,000.00 | $17,317,000.00 |
| Revenue This Year | N/A | $17.96 |
| Revenue Next Year | N/A | $55.64 |
| P/E Ratio | $7.41 | ★ N/A |
| Revenue Growth | ★ 107.11 | 18.76 |
| 52 Week Low | $6.10 | $1.98 |
| 52 Week High | $19.22 | $7.95 |
| Indicator | COHN | VVOS |
|---|---|---|
| Relative Strength Index (RSI) | 65.92 | 38.53 |
| Support Level | $16.31 | $1.98 |
| Resistance Level | $19.22 | $2.33 |
| Average True Range (ATR) | 1.21 | 0.15 |
| MACD | 0.28 | 0.01 |
| Stochastic Oscillator | 61.26 | 30.77 |
Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.